Adeline Duc

1.1k citations
18 papers · 775 indexed · h-index 13
Topics
Sarcoma Diagnosis and Treatment (5 papers)Immunotherapy and Immune Responses (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Adeline Duc

17 papers receiving 760 citations

Peers

Adeline Duc
Comparison fields: 5 of 75
  • Oncology 352
  • Molecular Biology 317
  • Cancer Research 246
  • Immunology 178
  • Pulmonary and Respiratory Medicine 173
Replace Min Tu with:
Min Tu China
Shaohui He China
Moubin Lin China
Jiren Yu China
Jolanta Pamuła‐Piłat Poland
Yuefeng Du China
Shenghua Zhan China
Nobuyuki Nishizawa Japan
Verena Sigl Austria
Maj Petersen Denmark
Adeline Duc relative to Min Tu China Min Tu's profile →
Citations per field
00.5×1.6×
Min Tu · 1×
Citations per year

Countries citing papers authored by Adeline Duc

Since Specialization
Citations

This map shows the geographic impact of Adeline Duc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeline Duc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeline Duc more than expected).

Fields of papers citing papers by Adeline Duc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adeline Duc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeline Duc. The network helps show where Adeline Duc may publish in the future.

Co-authorship network of co-authors of Adeline Duc

This figure shows the co-authorship network connecting the top 25 collaborators of Adeline Duc. A scholar is included among the top collaborators of Adeline Duc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adeline Duc. Adeline Duc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 0
3 18
4 35
5 74
6 11
7 92
8 16
9 115
10 22
11 249
12 32
13 48
14 13
15 29
16 1
17 18
18
[Treatment of renal cancer extending supradiaphragmatically with fibrinolytics following surgery under extracorporeal circulation, hypothermia and circulatory arrest].
1

About Adeline Duc

Adeline Duc is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 18 papers that have together received 775 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Cancer Research (246 citations), Oncology (352 citations) and Immunology (178 citations). Adeline Duc has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Jean‐Yves Blay, Christine Ménétrier‐Caux, Thomas Bachelot, Isabelle Ray‐Coquard, Laurent Alberti, Daniel Pissaloux, Angélique Gougèlet, Jennifer Perez, Aurélie Dutour and M Favrot. Their work appears in journals such as Cancer Research, British Journal of Cancer and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026